Tune Pers

The Pers Group's research focuses on the identification of central nervous system mechanisms through which genetic variants mediate susceptibility to obesity and type 2 diabetes. To that end, we leverage advanced model systems, machine learning, and CRISPR-based variant-to-function techniques. We employ physiologically relevant transgenic rodent models to validate our hypotheses and to bridge the gap between molecular discoveries and real-world therapeutic applications.